查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1820477

全球基因組學服務市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測（2025 年至 2033 年）

Global Genomics Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 138 Pages | 商品交期: 最快1-2個工作天內

價格

預計 2025 年至 2033 年間，全球基因組學服務市場將以 11.66% 的顯著複合年成長率成長。到 2033 年，市場規模預計將飆升至 243.1 億美元，較 2024 年的 90.1 億美元大幅成長。

受定序技術、生物資訊學和個人化醫療領域突破性進展的推動，基因組學服務市場正經歷指數級成長。基因組學服務涵蓋廣泛的服務，包括全基因組定序、基因表現分析和變異解讀，為科學研究、臨床診斷和藥物開發提供支援。定序成本和周轉時間的大幅縮短，使基因組資料的取得更加便捷，進而幫助大規模人口研究和精準醫療應用。雲端平台和人工智慧驅動的分析技術正在增強資料處理能力，促進從複雜的基因組資料集中獲取切實可行的洞察。

基因組學與其他組學學科和電子健康記錄的整合正在推動多維度患者分析，改善疾病風險預測、診斷和個人化治療。監管框架和資料隱私考量正在塑造服務交付模式，強調安全的資料管理和合乎倫理的資料使用。直接面對消費者的基因組學和藥物基因組學服務的擴展正在提高公眾的參與和認知。此外，學術機構、生物技術公司和醫療保健提供者之間的合作正在加速轉化研究和臨床應用。

隨著基因組學成為未來醫學和生物技術的核心，市場將持續成長，推動診斷、治療和人口健康管理的創新。

我們的報告經過精心設計，旨在為客戶提供關於各個行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵部分，以確保客戶全面了解市場格局：

市場概況：對市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本部分探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準，將市場細分為不同的細分市場。此分析重點在於突出每個細分市場的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本部分深入分析了領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，對特定時期的市場規模和成長趨勢進行預測。這包括定量分析和圖形表示，以說明未來的市場發展軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前及新興市場趨勢、技術創新和潛在投資領域。本部分提供對未來市場發展和成長前景的洞察。

涵蓋的細分市場列表

基因組學服務市場報告的此部分提供了國家和地區層面的細分詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按服務類型

  • 下一代定序
  • 基因分型
  • 微陣列
  • 桑格定序
  • 其他服務

按應用

  • 研究
  • 診斷

按最終用途

  • 研究機構
  • 診斷中心
  • 製藥和生物技術公司
  • 合約研究組織（CRO）
  • 其他最終用途
  • 報告中介紹的公司列表
  • 23andMe、安捷倫科技、BGI Genomics、Bio Rad Laboratories、Color Genomics、丹納赫、Eurofins Scientific、F. Hoffmann-La Roche、GE Healthcare、GENEWIZ (Azenta)、Illumina、LGC、Macrogen、IQVIA、QIAGEN

如果您有任何客製化需求，請聯絡我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第3章：基因組學服務 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按服務類型分析市場吸引力
    • 市場吸引力分析：按應用
    • 按最終用途進行的市場吸引力分析
    • 市場吸引力分析：按地區

第4章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第5章：全球基因體學服務市場分析：依服務類型

  • 依服務類型概覽
  • 按服務類型分析歷史和預測數據
  • 下一代定序
  • 基因分型
  • 微陣列
  • 桑格定序
  • 其他服務

第6章：全球基因組學服務市場分析：按應用

  • 概述：按應用
  • 歷史和預測數據分析：按應用
  • 研究
  • 診斷

第7章：全球基因組學服務市場分析：依最終用途

  • 按最終用途概覽
  • 按最終用途進行的歷史和預測數據分析
  • 研究機構
  • 診斷中心
  • 製藥和生物技術公司
  • 合約研究組織（CRO）
  • 其他最終用途

第 8 章：全球基因組學服務市場分析：按地區

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第9章：基因組學服務公司的競爭格局

  • 基因組學服務市場競爭
  • 夥伴關係/合作/協議
  • 併購
  • 新產品發布
  • 其他發展

第10章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • 23andMe
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Agilent Technologies
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BGI Genomics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bio Rad Laboratories
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Color Genomics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Danaher
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Eurofins Scientific
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • F. Hoffmann-La Roche
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • GE Healthcare
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • GENEWIZ (Azenta)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Illumina
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • LGC
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Macrogen
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • IQVIA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • QIAGEN
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，或者在私人公司的情況下可能不涵蓋

Product Code: VMR112117547

The Global Genomics Services market is forecasted to grow at a noteworthy CAGR of 11.66% between 2025 and 2033. By 2033, market size is expected to surge to USD 24.31 Billion, a substantial rise from the USD 9.01 Billion recorded in 2024.

The genomics services market is experiencing exponential growth fueled by breakthroughs in sequencing technologies, bioinformatics, and personalized medicine. Genomics services encompass a broad spectrum of offerings, including whole-genome sequencing, gene expression analysis, and variant interpretation, supporting research, clinical diagnostics, and drug development. The dramatic reduction in sequencing costs and turnaround times is democratizing access to genomic data, enabling large-scale population studies and precision healthcare applications. Cloud-based platforms and AI-driven analytics are enhancing data processing capabilities, facilitating actionable insights from complex genomic datasets.

The integration of genomics with other omics disciplines and electronic health records is advancing multi-dimensional patient profiling, improving disease risk prediction, diagnosis, and treatment customization. Regulatory frameworks and data privacy considerations are shaping service delivery models, emphasizing secure data management and ethical use. The expansion of direct-to-consumer genomics and pharmacogenomics services is increasing public engagement and awareness. Additionally, collaborations between academic institutions, biotech firms, and healthcare providers are accelerating translational research and clinical adoption.

As genomics becomes central to the future of medicine and biotechnology, the market is poised for sustained growth, driving innovation in diagnostics, therapeutics, and population health management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Genomics Services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service Type

  • Next Generation Sequencing
  • Genotyping
  • Microarray
  • Sanger Sequencing
  • Other Services

By Application

  • Research
  • Diagnostics

By End Use

  • Research Institutes
  • Diagnostic Centers
  • Pharmaceutical and Biotechnological Companies
  • Contract Research Organizations (CROs)
  • Other End Use
  • List of Companies Profiled in the report
  • 23andMe, Agilent Technologies, BGI Genomics, Bio Rad Laboratories, Color Genomics, Danaher, Eurofins Scientific, F. Hoffmann-La Roche, GE Healthcare, GENEWIZ (Azenta), Illumina, LGC, Macrogen, IQVIA, QIAGEN

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. GENOMICS SERVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End Use
    • 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL GENOMICS SERVICES MARKET ANALYSIS BY SERVICE TYPE

  • 5.1. Overview By Service Type
  • 5.2. Historical and Forecast Data Analysis By Service Type
  • 5.3. Next Generation Sequencing Historic and Forecast Sales By Regions
  • 5.4. Genotyping Historic and Forecast Sales By Regions
  • 5.5. Microarray Historic and Forecast Sales By Regions
  • 5.6. Sanger Sequencing Historic and Forecast Sales By Regions
  • 5.7. Other Services Historic and Forecast Sales By Regions

6. GLOBAL GENOMICS SERVICES MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Research Historic and Forecast Sales By Regions
  • 6.4. Diagnostics Historic and Forecast Sales By Regions

7. GLOBAL GENOMICS SERVICES MARKET ANALYSIS BY END USE

  • 7.1. Overview By End Use
  • 7.2. Historical and Forecast Data Analysis By End Use
  • 7.3. Research Institutes Historic and Forecast Sales By Regions
  • 7.4. Diagnostic Centers Historic and Forecast Sales By Regions
  • 7.5. Pharmaceutical and Biotechnological Companies Historic and Forecast Sales By Regions
  • 7.6. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions
  • 7.7. Other End Use Historic and Forecast Sales By Regions

8. GLOBAL GENOMICS SERVICES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE GENOMICS SERVICES COMPANIES

  • 9.1. Genomics Services Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF GENOMICS SERVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. 23andMe
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Agilent Technologies
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. BGI Genomics
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Bio Rad Laboratories
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Color Genomics
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Danaher
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Eurofins Scientific
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. F. Hoffmann-La Roche
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. GE Healthcare
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. GENEWIZ (Azenta)
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Illumina
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. LGC
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Macrogen
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. IQVIA
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. QIAGEN
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Service Type (USD MN)
  • Next Generation Sequencing Market Sales By Geography (USD MN)
  • Genotyping Market Sales By Geography (USD MN)
  • Microarray Market Sales By Geography (USD MN)
  • Sanger Sequencing Market Sales By Geography (USD MN)
  • Other Services Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Diagnostics Market Sales By Geography (USD MN)
  • Analysis By End Use (USD MN)
  • Research Institutes Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Pharmaceutical and Biotechnological Companies Market Sales By Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
  • Other End Use Market Sales By Geography (USD MN)
  • Global Genomics Services Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Genomics Services Report
  • Market Research Process
  • Market Research Methodology
  • Global Genomics Services Market Size, By Regions (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Service Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End Use
  • Market Attractiveness Analysis By Regions
  • Value Chain Analysis
  • Global Market Analysis By Service Type (USD MN)
  • Next Generation Sequencing Market Sales By Geography (USD MN)
  • Genotyping Market Sales By Geography (USD MN)
  • Microarray Market Sales By Geography (USD MN)
  • Sanger Sequencing Market Sales By Geography (USD MN)
  • Other Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Diagnostics Market Sales By Geography (USD MN)
  • Global Market Analysis By End Use (USD MN)
  • Research Institutes Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Pharmaceutical and Biotechnological Companies Market Sales By Geography (USD MN)
  • Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
  • Other End Use Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.